These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 31925953)
1. Epidemiology of Left Ventricular Assist Device Infections: Findings From a Large Nonregistry Cohort. Blanco-Guzman MO; Wang X; Vader JM; Olsen MA; Dubberke ER Clin Infect Dis; 2021 Jan; 72(2):190-197. PubMed ID: 31925953 [TBL] [Abstract][Full Text] [Related]
2. Incidence of Infection and Antimicrobial Consumption in Ventricular Assist Device (VAD) Recipients at the Prince Charles Hospital (TPCH): A Retrospective Analysis. Belz S; Fisquet S; Ahuja A; Hay K; Lavana J Heart Lung Circ; 2020 Aug; 29(8):1234-1240. PubMed ID: 32179022 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of infection in mechanical circulatory support: A global analysis from the ISHLT Mechanically Assisted Circulatory Support Registry. Hannan MM; Xie R; Cowger J; Schueler S; de By T; Dipchand AI; Chu VH; Cantor RS; Koval CE; Krabatsch T; Hayward CS; Nakatani T; Kirklin JK J Heart Lung Transplant; 2019 Apr; 38(4):364-373. PubMed ID: 30733158 [TBL] [Abstract][Full Text] [Related]
4. Stroke and death risk in ventricular assist device patients varies by ISHLT infection category: An INTERMACS analysis. Shah P; Birk SE; Cooper LB; Psotka MA; Kirklin JK; Barnett SD; Katugaha SB; Phillips S; Looby MM; Pagani FD; Cowger JA J Heart Lung Transplant; 2019 Jul; 38(7):721-730. PubMed ID: 30954340 [TBL] [Abstract][Full Text] [Related]
5. Infections in children with left ventricular assist device. Şen S; Ülger Z; Şahbudak Bal Z; Özbaran M Transpl Infect Dis; 2020 Dec; 22(6):e13439. PubMed ID: 32767830 [TBL] [Abstract][Full Text] [Related]
6. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary. Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262 [TBL] [Abstract][Full Text] [Related]
7. Minimum inhibitory concentration changes in relapsed left ventricular assist device driveline infections. Lines TH; Sabato LA; Nesbitt WJ; Moretz JD; Brinkley DM; Satyanarayana G Int J Artif Organs; 2020 Jul; 43(7):494-499. PubMed ID: 31964206 [TBL] [Abstract][Full Text] [Related]
11. Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site. Letsou GV; Anand J; Ogburn E; Shah RM; Ganapathy AV; Cohn WE; Loor G; Frazier OH Tex Heart Inst J; 2019 Jun; 46(3):179-182. PubMed ID: 31708699 [TBL] [Abstract][Full Text] [Related]
12. The value of fluorine-18 deoxyglucose positron emission tomography scans in patients with ventricular assist device specific infections†. Bernhardt AM; Pamirsad MA; Brand C; Reichart D; Tienken M; Barten MJ; Schaefer A; Grahn H; Rybczynski M; Deuse T; Reichenspurner H; Wagner FM Eur J Cardiothorac Surg; 2017 Jun; 51(6):1072-1077. PubMed ID: 28329162 [TBL] [Abstract][Full Text] [Related]
13. Infections in Patients With Left Ventricular Assist Devices: Current State and Future Perspectives. Inglis SS; Suh GA; Razonable RR; Schettle SD; Spencer PJ; Villavicencio MA; Rosenbaum AN ASAIO J; 2023 Jul; 69(7):633-641. PubMed ID: 37145863 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices. Jennings DL; Chopra A; Chambers R; Morgan JA Artif Organs; 2014 Oct; 38(10):875-9. PubMed ID: 24571683 [TBL] [Abstract][Full Text] [Related]
15. Ventricular assist device-related infections and solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Koval CE; Stosor V; Clin Transplant; 2019 Sep; 33(9):e13552. PubMed ID: 30924952 [TBL] [Abstract][Full Text] [Related]
17. Contributory Role of Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis and Clinical Management of Infections in Patients Supported With a Continuous-Flow Left Ventricular Assist Device. Dell'Aquila AM; Mastrobuoni S; Alles S; Wenning C; Henryk W; Schneider SR; Deschka H; Sindermann JR; Scherer M Ann Thorac Surg; 2016 Jan; 101(1):87-94; discussion 94. PubMed ID: 26433521 [TBL] [Abstract][Full Text] [Related]
18. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices. Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303 [TBL] [Abstract][Full Text] [Related]
19. Driveline Site Is Not a Predictor of Infection After Ventricular Assist Device Implantation. Martin BJ; Luc JGY; Maruyama M; MacArthur R; Bates AR; Buchholz H; Freed DH; Conway J ASAIO J; 2018; 64(5):616-622. PubMed ID: 29035899 [TBL] [Abstract][Full Text] [Related]
20. Bacteraemia in ventricular assist devices: a common complication that need not affect clinical outcomes. Rosenfeldt FL; Kwa LJ; Porapakkham P; Rajadurai S; Jones K; van de Merwe J; Billah B; Porapakkham P; Esmore DS; Halvorsen DS; Aguirre VJ; Spelman DW Heart Lung Circ; 2014 Mar; 23(3):234-41. PubMed ID: 24268488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]